Name: Latest research reports of Ajanta Pharma Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Ajanta Pharma Ltd.
Rating: 5
Author: Motilal Oswal

Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Expensive Rocket

3345.0000 18.70 (0.56%)

NSE Jul 06, 2026 11:40 AM

New 52W High in past week

Volume: 45,619

Ajanta Pharma Ltd.

05 May 2026, 12:00AM

3345.00

0.56%

Strong beat on our 4Q estimates; robust outlook

Buy: Ajanta Pharma Ltd.

Motilal Oswal

Ajanta Pharma (AJP) delivered a better-than-expected 4QFY26, with a 10%/17%/21% beat on our revenue/EBITDA/PAT estimates.

Ajanta Pharma Ltd. is trading above all available SMAs